Ataxia telangiectasia: why should the ERS care?

Jayesh M. Bhatt*, Andrew Bush, Marjo van Gerven, Andreea Nissenkorn, Michael Renke, Lian Yarlett, Malcolm Taylor, Thorny Tonia, Adilia Warris, Stefan Zielen, Shairbanu Zinna, Peter J. F. M. Merkus

*Corresponding author for this work

Research output: Contribution to journalEditorialpeer-review

7 Citations (Scopus)


Neurological and immunological contributions to lung disease in A-T require proactive and multidisciplinary management

Why indeed should we care? The answer is that ataxia telangiectasia (A-T) patients will present to respiratory paediatricians for diagnosis, when standard testing, if the diagnosis is not made, may do irreparable harm; and both adult and paediatric respiratory physicians will be involved in managing the respiratory disease, which is a major cause of morbidity and mortality. So there is a real “need to know” which is why the ERS convened a task force on A-T, whose findings are published in the European Respiratory Review [1].
Original languageEnglish
Pages (from-to)1557-1560
Number of pages4
JournalEuropean Respiratory Journal
Issue number6
Early online date30 Nov 2015
Publication statusPublished - 1 Dec 2015


  • lung-disease
  • nutritional-status
  • immunodeficiency
  • infections
  • deficiency
  • child


Dive into the research topics of 'Ataxia telangiectasia: why should the ERS care?'. Together they form a unique fingerprint.

Cite this